0001189724-17-000003.txt : 20170227 0001189724-17-000003.hdr.sgml : 20170227 20170227141238 ACCESSION NUMBER: 0001189724-17-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170224 FILED AS OF DATE: 20170227 DATE AS OF CHANGE: 20170227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIGGS STEVEN CENTRAL INDEX KEY: 0001189724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 17640966 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL INC STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-02-24 0 0000883984 ICU MEDICAL INC/DE ICUI 0001189724 RIGGS STEVEN 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 VP Operations Common Stock 2017-02-24 4 X 0 16250 58.79 A 17576 D Common Stock 2017-02-24 4 S 0 4500 151.3881 D 13076 D Common Stock 2017-02-24 4 S 0 11750 152.2282 D 1326 D Common Stock 2017-02-24 4 X 0 15000 58.79 A 16326 D Common Stock 2017-02-24 4 S 0 4796 151.4907 D 11530 D Common Stock 2017-02-24 4 S 0 10204 152.2044 D 1326 D Non-Qualified Stock Option (right to buy) 58.79 2017-02-24 4 X 0 16250 58.79 D 2024-02-24 Common Stock 16250 46250 D Non-Qualified Stock Option (right to buy) 58.79 2017-02-24 4 X 0 15000 58.79 D 2024-02-24 Common Stock 15000 31250 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Transaction is the exercise of a derivative security; see Column 2. By: Paula Darbyshire, Attorney-in-fact For: Steven C. Riggs 2017-02-27